Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Temporomandibular joint

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    Study title: Bush FM, Harrington WG, Harkins SW. Interexaminer comparison of bone scintigraphy and panoramic radiography of temporomandibular joints: correlation with signs and symptoms. J Prosthet Dent. 1992 Feb;67(2):246-51. Bush FM, Harrington WG, Harkins SW. Interexaminer comparison of bone scintigraphy and panoramic radiography of temporomandibular joints: correlation with signs and symptoms. J Prosthet Dent. 1992 Feb;67(2):246-51.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43710
    Study title: Collier BD, Carrera GF, Messer EJ, Ryan DE, Gingrass D, Angell D, Palmer DW, Isitman AT, Hellman RS. Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progress. Radiology. 1983 Nov;149(2):557-61. Collier BD, Carrera GF, Messer EJ, Ryan DE, Gingrass D, Angell D, Palmer DW, Isitman AT, Hellman RS. Internal derangement of the temporomandibular joint: detection by single-photon emission computed tomography. Work in progress. Radiology. 1983 Nov;149(2):557-61.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44277
    Study title: Effect of indomethacin phonophoresis on the relief of temporomandibular joint pain.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29883
    Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44228
    Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44275
    Study title: Paulsen HU, Rabøl A, Sørensen SS. Bone scintigraphy of human temporomandibular joints during Herbst treatment: a case report. Eur J Orthod. 1998 Aug;20(4):369-74. Paulsen HU, Rabøl A, Sørensen SS. Bone scintigraphy of human temporomandibular joints during Herbst treatment: a case report. Eur J Orthod. 1998 Aug;20(4):369-74.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43525
    Study title: Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. [Semiquantitative SPECT of anterior dislocation of the temporomandibular joint disk] Rofo. 1987 Jan;146(1):13-7. German. Erratum in: ROFO 1987 Apr;146(4):487. Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. [Semiquantitative SPECT of anterior dislocation of the temporomandibular joint disk] Rofo. 1987 Jan;146(1):13-7. German. Erratum in: ROFO 1987 Apr;146(4):487.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43886
    Study title: Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. Semiquantitative SPECT imaging for assessment of bone reactions in internal derangements of the temporomandibular joint. J Oral Maxillofac Surg. 1987 Dec;45(12):1022-8. Oesterreich FU, Jend-Rossmann I, Jend HH, Triebel HJ. Semiquantitative SPECT imaging for assessment of bone reactions in internal derangements of the temporomandibular joint. J Oral Maxillofac Surg. 1987 Dec;45(12):1022-8.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43840
    Study title: Tindale WB, Martel AL, Barber DC. The use of image registration in the analysis of bone scans for the assessment of temporomandibular joint uptake. Nucl Med Commun. 1999 Jan;20(1):49-59. Tindale WB, Martel AL, Barber DC. The use of image registration in the analysis of bone scans for the assessment of temporomandibular joint uptake. Nucl Med Commun. 1999 Jan;20(1):49-59.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43517
    Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43855
    Study title: Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74. Krasnow AZ, Collier BD, Kneeland JB, Carrera GF, Ryan DE, Gingrass D, Sewall S, Hellman RS, Isitman AT, Froncisz W, et al. Comparison of high-resolution MRI and SPECT bone scintigraphy for noninvasive imaging of the temporomandibular joint. J Nucl Med. 1987 Aug;28(8):1268-74.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44181
    Study title: Kvien, T. K., Larheim, T. A., Hoyeraal, H. M., and Sandstad, B. Radiographic temporomandibular joint abnormalities in patients with juvenile chronic arthritis during a controlled study of sodium aurothiomalate and D-penicillamine Br.J.Rheumatol. 1986;25:59-66. Kvien, T. K., Larheim, T. A., Hoyeraal, H. M., and Sandstad, B. Radiographic temporomandibular joint abnormalities in patients with juvenile chronic arthritis during a controlled study of sodium aurothiomalate and D-penicillamine Br.J.Rheumatol. 1986;25:59-66.
    Active substance: PENICILLAMINE
    Study summary document link (including results):
    View full study record
    Document reference: 33842
    Study title: Radiographic temporomandibular joint abnormalities in patients with juvenile chronic arthritis during a controlled study of sodium aurothiomalate and D-penicillamine Radiographic temporomandibular joint abnormalities in patients with juvenile chronic arthritis during a controlled study of sodium aurothiomalate and D-penicillamine
    Active substance: PENICILLAMINE
    Study summary document link (including results):
    View full study record
    Document reference: 33849
    Study title: EVALUATION OF THE EFFICACY AND TOLERATION OF PIROXICAM AS ADJUVANT THERAPY IN THE TREATMENT OF THE PAIN-DYSFUNCTION SYNDROME OF THE TEMPOROMANDIBULAR JOINT.
    Active substance: PIROXICAM
    Study summary document link (including results):
    View full study record
    Document reference: 34340
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Jun 02 03:59:43 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA